Gene: UBR7
Official Full Name: ubiquitin protein ligase E3 component n-recognin 7provided by HGNC
Gene Summary: This gene encodes a UBR box-containing protein that belongs to the E3 ubiquitin ligase family. The protein also contains a plant homeodomain (PHD) in the C-terminus. In mammals, the encoded protein recognizes N-degrons, the destabilizing N-terminal residues of short-lived proteins, which results in ubiquitinylation, and proteolysis via the proteasome. [provided by RefSeq, Jul 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12843 | UBR7 Knockout cell line (HeLa) | Human | UBR7 | 1:3~1:6 | Negative | Online Inquiry |
KO12844 | UBR7 Knockout cell line (HCT 116) | Human | UBR7 | 1:2~1:4 | Negative | Online Inquiry |
KO12845 | UBR7 Knockout cell line (HEK293) | Human | UBR7 | 1:3~1:6 | Negative | Online Inquiry |
KO12846 | UBR7 Knockout cell line (A549) | Human | UBR7 | 1:3~1:4 | Negative | Online Inquiry |
UBR7 Gene Knockout Cell Lines are genetically engineered cell lines in which the UBR7 gene, associated with the ubiquitin-proteasome degradation pathway, has been selectively disrupted. This knockout model provides a powerful tool for investigating the role of UBR7 in cellular processes, such as protein turnover, cellular stress responses, and disease mechanisms. By eliminating the UBR7 expression, researchers can study the downstream effects on protein stability, gene expression, and various signaling pathways.
The primary mechanism through which UBR7 exerts its influence involves the ubiquitination process, wherein proteins are tagged for degradation or modification. UBR7 plays a critical role in recognizing and marking specific substrates for proteasomal degradation, thus regulating various cellular functions. By utilizing UBR7 knockout cell lines, researchers can elucidate the contributions of UBR7 to pathologies such as cancer, neurodegenerative disorders, and cellular aging.
In research and clinical settings, these knockout cell lines are invaluable for understanding the implications of UBR7 dysregulation. For instance, they can be used to model specific diseases, screen for small molecules that might reverse UBR7-associated defects, or test novel therapeutic strategies targeting the ubiquitin-proteasome system. The specificity of these cell lines allows for precise manipulation of cellular environments, yielding reproducible and reliable data essential for advancing scientific knowledge.
What sets UBR7 Gene Knockout Cell Lines apart from other genetic tools is their robust genetic characterization and the availability of a versatile platform for both in vitro and in vivo studies. Unlike traditional knockdown methods, which may only partially inhibit gene function, knockout cell lines ensure complete gene deletion, leading to a clearer understanding of UBR7's role.
For researchers and clinicians, the value of UBR7 Gene Knockout Cell Lines lies in their potential to unlock novel insights into cellular regulation and disease mechanisms. By using these lines, users can accelerate their research, develop new therapies, and contribute to the broader understanding of the human proteome. Our company is committed to producing high-quality biological products backed by rigorous scientific expertise, ensuring that customers have access to the most innovative and effective tools for their research needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.